Treatment of Drug Users: Chapter 8

The committee recommends that priorities for the funding of treatment evaluation research should be changed; large-scale, national treatment inventory studies should not be conducted at the expense of greater funding for randomized controlled clinical trials.

249

NIDA

X

 

 

The committee recommends greater scientific attention to now-missed opportunities to conduct randomized trials of drug treatments with no-treatment control conditions.

258

NIDA

X

 

 

The committee recommends that treatment researchers take greater advantage of possible opportunities for randomization to no-treatment control groups. For example, we strongly encourage studies of incarcerated and postincarcerated prisoners as outlined in this report. The committee urges federal and state agencies and private institutions to minimize organizational obstacles to such studies, within ethical and legal bounds.

263

NIDA

X

 

 

The committee strongly recommends that treatments intended to benefit people be evaluated in carefully conducted randomized controlled experiments.

263

NIDA

X

 

 

The committee recommends broader use of meta-analytic techniques for cumulating and comparing findings across treatment outcome studies.

265

NIDA

X

 

 



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement